|
Market Closed -
NYSE
23:00:00 15/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 42.05 USD | +1.87% |
|
+4.03% | +60.56% |
Main features
| US46435U1925 | Fees | 0.47% | Dividend Policy | Distribution | |
|---|---|---|---|---|---|
| Currency | USD | AuM (SAR) | 906.18M | Replication Method | Direct (Physical) |
| Number of securities | 52 | AuM evolution | - | Date of creation | 11/06/2019 |
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
CBOE
| IDNA | Real-time | |
NYSE
| IDNA | Delayed |
| Name |
Off-Hours Price |
Change |
Weight | |
|---|---|---|---|---|
 | 44.41EUR | -1.46% | 4.51% | |
| 6,244.00JPY | +0.99% | 4.37% | |
| 796.34USD | +2.31% | 4.33% | |
| 334.90CHF | -1.35% | 4.31% | |
| 236.50USD | +4.51% | 4.29% | |
| 145.19USD | -1.48% | 4.25% | |
| 1,868.50GBX | +2.89% | 4.1% | |
| 2,529.00DKK | +1.93% | 4.05% | |
| 189.26USD | -2.20% | 4.03% | |
| 508.75USD | +2.06% | 4.01% | |
Easily sort and filter through all available ETFs
Access the ETF ScreenerEconomic news
In partnership with
Investment objective
| Asset Classes | Stocks |
|---|---|
| Geographical Focus | - |
| Theme and Sector | BioTech & Genomics |
The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/10/26 | $42.05 | +1.87% | 107,612 |
| 14/10/26 | $41.28 | +1.20% | 291,188 |
| 13/10/26 | $40.79 | -1.85% | 108,631 |
| 12/10/26 | $41.56 | -1.45% | 144,354 |
| 09/10/26 | $42.17 | +4.33% | 151,584 |
- Stock Market
- ETF
- IDNA ETF
Select your edition
All financial news and data tailored to specific country editions
